Tevogen Bio (TVGN) News Today $1.05 +0.02 (+1.94%) (As of 05:46 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Sees Large Decline in Short InterestTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 1,180,000 shares, a decrease of 21.3% from the November 30th total of 1,500,000 shares. Based on an average trading volume of 16,290,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.5% of the shares of the stock are short sold.December 29 at 7:47 AM | marketbeat.comTevogen Bio to Host Panels on AI in Biopharma and Healthcare Economics at 2025 JPM Healthcare ConferenceDecember 28 at 1:03 PM | nasdaq.comTevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare ConferenceDecember 26, 2024 | globenewswire.comTevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comTevogen Bio (TVGN) Advances AI-Driven Immunotherapy with New Patent FilingDecember 20, 2024 | insidermonkey.comTevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth AgendaDecember 19, 2024 | globenewswire.comTevogen Bio Holdings Inc.: Excessive Insider Ownership And Poised For A Seasonal ReboundDecember 18, 2024 | seekingalpha.comTevogen Bio to Host Panel "Pioneering the Economics of Health: Balancing Access and Outcomes" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | tmcnet.comTevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | globenewswire.comTevogen Bio Claims $10 Billion IP Potential But Hinges On MonetizationDecember 17, 2024 | seekingalpha.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 93.6% in NovemberTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 1,500,000 shares, a growth of 93.6% from the November 15th total of 774,700 shares. Currently, 6.7% of the shares of the stock are short sold. Based on an average trading volume of 16,110,000 shares, the short-interest ratio is currently 0.1 days.December 12, 2024 | marketbeat.comTevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 10, 2024 | globenewswire.comDr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of FameDecember 5, 2024 | globenewswire.comTevogen Bio Holdings IncNovember 27, 2024 | morningstar.comTevogen Bio (NASDAQ:TVGN) Stock Price Down 5.6% - Should You Sell?Tevogen Bio (NASDAQ:TVGN) Trading Down 5.6% - Here's What HappenedNovember 27, 2024 | marketbeat.comTevogen Bio Prepares Organizational Readiness to Support Company’s Growth StrategyNovember 26, 2024 | markets.businessinsider.comTevogen Bio Prepares Organizational Readiness to Support Company's Growth StrategyNovember 26, 2024 | globenewswire.comTevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company ValueNovember 21, 2024 | globenewswire.comTevogen reports Q3 EPS (3c) vs (3c) last yearNovember 20, 2024 | markets.businessinsider.comTevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business ModelNovember 19, 2024 | globenewswire.comUPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Bio Shares Are On The Rise Monday: What's Going On?November 11, 2024 | benzinga.comTevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued OperationsNovember 8, 2024 | globenewswire.comTevogen Bio advances HPV oncology treatment TVGN 920November 7, 2024 | uk.investing.comTevogen Bio partners Microsoft for HPV treatmentNovember 6, 2024 | finance.yahoo.comTevogen Bio boekt vooruitgang met HPV-oncologiebehandeling TVGN 920November 6, 2024 | nl.investing.comTevogen leverages Microsoft partnership to deliver target identification for HPVNovember 5, 2024 | markets.businessinsider.comTevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920November 5, 2024 | globenewswire.comTevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient SupportNovember 4, 2024 | globenewswire.comTevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing CostsOctober 31, 2024 | globenewswire.comTevogen Bio Inc: Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the CompanyOctober 30, 2024 | finanznachrichten.deTevogen regains compliance with NasdaqOctober 30, 2024 | markets.businessinsider.comTevogen Bio plant nieuwe R&D- en productiefaciliteitOctober 29, 2024 | nl.investing.comTevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the CompanyOctober 29, 2024 | globenewswire.comAlpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 MillionOctober 29, 2024 | globenewswire.comTevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder EquityOctober 29, 2024 | globenewswire.comTevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic AreasOctober 25, 2024 | globenewswire.comTevogen Bio (NASDAQ:TVGN) Shares Gap Down - Time to Sell?Tevogen Bio (NASDAQ:TVGN) Shares Gap Down - What's Next?October 25, 2024 | marketbeat.comShort Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Expands By 450.9%Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 3,190,000 shares, an increase of 450.9% from the September 30th total of 579,000 shares. Currently, 14.5% of the shares of the company are short sold. Based on an average daily volume of 13,960,000 shares, the short-interest ratio is currently 0.2 days.October 25, 2024 | marketbeat.comTevogen AI joins Microsoft for StartupsOctober 23, 2024 | markets.businessinsider.comTevogen Bio Shares Are Soaring Wednesday: What's Going On?October 23, 2024 | msn.comTevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug DevelopmentOctober 23, 2024 | globenewswire.comTevogen says CSO share sale ‘solely’ to satisfy payment of tax obligationsOctober 22, 2024 | markets.businessinsider.comTevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22, 2024 | globenewswire.comInsider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells 1,078,600 Shares of StockOctober 22, 2024 | insidertrades.comTevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 BillionOctober 21, 2024 | globenewswire.comTevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming DaysOctober 21, 2024 | globenewswire.comTevogen Bio projects $1 billion oncology revenueOctober 20, 2024 | investing.comTevogen CEO Expresses Gratitude for Unprecedented Public Support of Company's Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming DaysOctober 18, 2024 | globenewswire.com Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious drone activity triggers massive 1,366% surge (Ad)If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%. 👉 Click here now to see how this signal works. TVGN Media Mentions By Week TVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼0.480.59▲Average Medical News Sentiment TVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼43▲TVGN Articles Average Week Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CARGO Therapeutics News Today Exscientia News Today Humacyte News Today Autolus Therapeutics News Today VectivBio News Today Ginkgo Bioworks News Today Tourmaline Bio News Today Sangamo Therapeutics News Today ProKidney News Today Kodiak Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
